Medy-Tox Inc (086900) — Free Cash Flow Generation Index
Medy-Tox Inc (086900) has a Free Cash Flow Generation Index of 0.66x as of September 2025. Free cash flow of ₩12.57 Billion represents 1% of operating cash flow (₩19.03 Billion). Explore Medy-Tox Inc (086900) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Medy-Tox Inc Free Cash Flow Generation Index (2013–2024)
Historical FCF Generation Index trend for Medy-Tox Inc across 12 annual periods. For the full cash flow conversion analysis, see how efficiently does Medy-Tox Inc generate cash.
Annual Free Cash Flow Generation for Medy-Tox Inc (2013–2024)
Year-by-year Free Cash Flow Generation Index for Medy-Tox Inc. Check 086900 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.48x | ₩17.83 Billion | ₩36.89 Billion | ₩18.72 Billion | ▲ +127.3% |
| 2023 | -1.77x | ₩-23.95 Billion | ₩13.52 Billion | ₩37.47 Billion | ▼ -4322.4% |
| 2022 | 0.04x | ₩1.10 Billion | ₩26.20 Billion | ₩9.90 Billion | ▲ +160.8% |
| 2021 | -0.07x | ₩-1.38 Billion | ₩19.97 Billion | ₩17.51 Billion | ▲ +88.2% |
| 2020 | -0.59x | ₩-16.38 Billion | ₩27.93 Billion | ₩41.14 Billion | ▼ -136.1% |
| 2019 | 1.62x | ₩54.72 Billion | ₩33.70 Billion | ₩21.02 Billion | ▲ +40.7% |
| 2018 | 1.15x | ₩63.57 Billion | ₩55.07 Billion | ₩8.50 Billion | ▼ -31.0% |
| 2017 | 1.67x | ₩94.59 Billion | ₩56.55 Billion | ₩38.04 Billion | ▼ -54.5% |
| 2016 | 3.67x | ₩198.77 Billion | ₩54.10 Billion | ₩144.67 Billion | ▲ +46.3% |
| 2015 | 2.51x | ₩56.18 Billion | ₩22.37 Billion | ₩33.81 Billion | ▲ +116.9% |
| 2014 | 1.16x | ₩122.01 Billion | ₩105.38 Billion | ₩16.64 Billion | ▼ -42.0% |
| 2013 | 2.00x | ₩33.15 Billion | ₩16.60 Billion | ₩16.55 Billion | — |